Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

Real-time Estimate Tradegate 11:09:40 18/09/2026 +03			5-day change	1st Jan Change
58.80 ^EUR	+0.60%		+1.83%	-7.66%

07-23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
07-23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Consensus
ELI LILLY AND COMPANY	1,027B		A
JOHNSON & JOHNSON	651B	-	BBB	-		-
ABBVIE INC.	467B		AAA			-
ROCHE HOLDING AG	350B		AA
NOVARTIS AG	268B		AAA
ASTRAZENECA PLC	257B		A
AMGEN INC.	205B		A
NOVO NORDISK A/S	190B		BBB
GILEAD SCIENCES, INC.	187B		AA
PFIZER INC.	158B		A
VERTEX PHARMACEUTICALS INCORPORATED	131B		AA
BRISTOL-MYERS SQUIBB COMPANY	128B		A
SANOFI	104B		A
GSK PLC	102B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.58B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	60.94B		AA
BAYER AG	55.31B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	45.67B		A		-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	42.47B		AA
Average	236.79B		AA
Weighted average by Cap.			AA